Drug Trial News

RSS
Auspex enrolls first patient in SD-809 Phase 3 trial for treatment of chorea associated with HD

Auspex enrolls first patient in SD-809 Phase 3 trial for treatment of chorea associated with HD

12 Jul 2013
Alnylam releases positive top-line data from ALN-TTRsc Phase I trial for TTR-mediated amyloidosis

Alnylam releases positive top-line data from ALN-TTRsc Phase I trial for TTR-mediated amyloidosis

12 Jul 2013
Phase III study: REVLIMID meets primary endpoint in patients newly diagnosed with multiple myeloma

Phase III study: REVLIMID meets primary endpoint in patients newly diagnosed with multiple myeloma

11 Jul 2013
UNMC conducts clinical trial on Leukine to test unique immune therapy in people with Parkinson's

UNMC conducts clinical trial on Leukine to test unique immune therapy in people with Parkinson's

11 Jul 2013
Ohr Pharmaceutical enrolls first 60 patients in OHR-002 Phase II clinical trial for wet-AMD treatment

Ohr Pharmaceutical enrolls first 60 patients in OHR-002 Phase II clinical trial for wet-AMD treatment

10 Jul 2013
Innovative vaccine could offer hope to patients with advanced ovarian cancer

Innovative vaccine could offer hope to patients with advanced ovarian cancer

10 Jul 2013
Anti-cancer compounds offer hope for treating breast cancer

Anti-cancer compounds offer hope for treating breast cancer

9 Jul 2013
VBL Therapeutics publishes VB-201 pre-clinical data in journal of Atherosclerosis

VBL Therapeutics publishes VB-201 pre-clinical data in journal of Atherosclerosis

8 Jul 2013
Bayer starts enrollment in BAY94-9027 Phase II/III trial for hemophilia A in children

Bayer starts enrollment in BAY94-9027 Phase II/III trial for hemophilia A in children

8 Jul 2013
Probiodrug to present studies on PQ912 for treatment of Alzheimer's disease at AAIC meeting

Probiodrug to present studies on PQ912 for treatment of Alzheimer's disease at AAIC meeting

8 Jul 2013
Biogen, Sobi present new data supporting clinical, safety profile of ELOCTATE for hemophilia A

Biogen, Sobi present new data supporting clinical, safety profile of ELOCTATE for hemophilia A

4 Jul 2013
Prana gets Austin HREC approval for 12-month open label extension study of PBT2 in Alzheimer’s patients

Prana gets Austin HREC approval for 12-month open label extension study of PBT2 in Alzheimer’s patients

4 Jul 2013
ERYTECH reports fast take-off of GRASPA Phase IIb trial in patients with acute myeloid leukemia

ERYTECH reports fast take-off of GRASPA Phase IIb trial in patients with acute myeloid leukemia

4 Jul 2013
MGN1703 drug provides a new treatment approach to colorectal cancer

MGN1703 drug provides a new treatment approach to colorectal cancer

4 Jul 2013
Pergamum: LL-37 Phase I/II trial meets primary end-point in patients with venous leg ulcers

Pergamum: LL-37 Phase I/II trial meets primary end-point in patients with venous leg ulcers

4 Jul 2013
CTI announces publication of preclinical, clinical data for pacritinib in Drugs of the Future 2013

CTI announces publication of preclinical, clinical data for pacritinib in Drugs of the Future 2013

3 Jul 2013
Biogen, Sobi present new findings from Phase 3 trial of ALPROLIX at XXIV ISTH Congress

Biogen, Sobi present new findings from Phase 3 trial of ALPROLIX at XXIV ISTH Congress

3 Jul 2013
Array BioPharma achieves milestone for initiation of MEK162 Phase 3 trial in patients with LGSOC

Array BioPharma achieves milestone for initiation of MEK162 Phase 3 trial in patients with LGSOC

2 Jul 2013
Alnylam Pharmaceuticals presents new pre-clinical data of ALN-AT3 at ISTH meeting

Alnylam Pharmaceuticals presents new pre-clinical data of ALN-AT3 at ISTH meeting

2 Jul 2013
Study shows that PCCs can reverse blood thinning effects of XARELTO in healthy subjects

Study shows that PCCs can reverse blood thinning effects of XARELTO in healthy subjects

2 Jul 2013

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback